Article de Périodique
Drug policy, values and the public health approach - four lessons from drug policy reform movements (2015)
Auteur(s) :
ROGEBERG, O. (Auteur) ;
BABOR, T. F. (Auteur du commentaire) ;
ROOM, R. (Auteur du commentaire)
Année :
2015
Page(s) :
347-364
Langue(s) :
Anglais
Domaine :
Alcool / Alcohol ; Drogues illicites / Illicit drugs ; Tabac / Tobacco / e-cigarette
Discipline :
SAN (Santé publique / Public health)
Thésaurus mots-clés
SANTE PUBLIQUE
;
POLITIQUE
;
RECHERCHE
;
LEGALISATION
;
MARCHE DE LA DROGUE
Thésaurus géographique
INTERNATIONAL
Note générale :
Commentaries:
Babor, T. (2015). Welcome to Hotel California: Comments on Rogeberg (2015). Nordic Studies on Alcohol and Drugs, 32(4), pp. 365-366.
Room, R. (2015). Public health, the public good, and drug policy. Nordic Studies on Alcohol and Drugs, 32(4), pp. 367-370.
Rogeberg, O. (2015). Drug policy, public health and values revisited. Nordic Studies on Alcohol and Drugs, 32(4), pp. 371-373
Babor, T. (2015). Welcome to Hotel California: Comments on Rogeberg (2015). Nordic Studies on Alcohol and Drugs, 32(4), pp. 365-366.
Room, R. (2015). Public health, the public good, and drug policy. Nordic Studies on Alcohol and Drugs, 32(4), pp. 367-370.
Rogeberg, O. (2015). Drug policy, public health and values revisited. Nordic Studies on Alcohol and Drugs, 32(4), pp. 371-373
Résumé :
Drug policies affect a large set of outcomes and may reflect the concerns of several policy stakeholder groups. Researchers analysing policies typically employ a public health approach, extended to reflect concerns beyond population health and longevity. I argue that the resulting approach, as currently practised, fails to capture several concerns seen as important by recent drug policy reform movements, that is, the full harms of illegal markets, the subjectively valued consumption of intoxicants, the dysfunctionality of current policy processes in the drug field and the value of the knowledge gained from policy experiments. I illustrate this by referring to the book Drug policy and the public good, a public health-based review of research evidence and its relevance for drug policy written by leading international researchers in the field.
Affiliation :
Ragnar Frisch Centre for Economic Research, Norway